Co-Founder, CEO

- Biotech operator & former CEO, led Global Biolife’s R&D and drug development programs in neurology, oncology, and immunology, guiding the company through growth and acquisition by a NYSE-listed firm (DSS).

- Veteran chemical engineer from Merck with leadership in process development and execution for Nexium and Prilosec.

- Ph.D. from Columbia, published in polymer diffusion, antiviral chemistry, and materials engineering, and co-inventor on multiple patents related to advanced coatings and chemical processes.

- Seasoned founder and strategic operator, experienced in venture creation, capital deployment, and regulatory navigation

Co-Founder, Chief Scientific Officer

- 30+ years (Pfizer, GSK, Merck) leading precision medicine, drug development, and clinical translation for major oncology assets

- Senior Dir. at Pfizer, driving global biomarker programs; defining resistance mechanisms (CDK4/6 inhibitor), advancing ctDNA analytics, and shaping Phase II/III clinical designs.

- Extensive regulatory and companion diagnostic leadership, steering diagnostic development for targeted therapies in cancer treatment.

- Widely published (Nature, JCO, CCR) and internationally recognized scientist, with high-impact papers and presentations at ASCO, AACR, SABCS, and ESMO.

- Co-inventor on multiple patents related to drug discovery.

Co-Founder, Chief Technology Officer

- Principal Informatics Scientist at NIH, expertise in AI, ML, cheminformatics, and large-scale biological data systems, including designing algorithms, 3D pathway visualizations, qHTS analytics, and the BioPlanet pathway platform now used by the EPA

- Developer of 20+ high-accuracy ADMET machine-learning models and creator of Retro Drug Design —a pioneering generative AI paradigm capable of designing novel compounds with tailored efficacy and ADMET profiles.

- Led major informatics and drug discovery infrastructure (GSK, Merck) including high-throughput combination analysis systems, integrative databases, protein folding algorithms, genome reconstruction tools, and enterprise-scale LIMS and data warehouses.

- Publications in (Science, Nature, PNAS) and national awards, recognized for breakthroughs in computational biology, global optimization, and AI-driven drug discovery.

VP, Operations

- Led an organizational restructure and expansion, doubling revenue within first 3 years

- Executed strategic merger, including negotiations, integration, change management, and established cross-institutional leadership.

- Built high-performing teams, with an expertise across strategic planning, fundraising, finance, marketing, PR, and market positioning.

- Steered high-visibility educational programming under tight constraints. Achieved yearly 100% college matriculation rate for under-resourced children in Philadelphia.

- Awarded numerous grants from government and private funding agencies.

- international award-winning harpist with performance credits at Carnegie Hall, The Kennedy Center. Won a 2021 GRAMMY and received three GRAMMY nominations.

Chairman